From the category archives:

News

Meridia safety reviewed by FDA

Thumbnail image for Meridia safety reviewed by FDA

A new study of the weight loss drug Meridia is in the hands of FDA regulators, who’ve released an early communication based on preliminary data: certain patients taking the drug may have a higher risk of heart attacks, strokes, and other serious cardiovascular problems.
The recent study tested Meridia ( sibutramine) in overweight or obese people [...]

Read the full article →

News About Weight-Loss Drugs

Thumbnail image for News About Weight-Loss Drugs

One new treatment for obesity was approved by the U.S. Food and Drug Administration in 2007, but a second, more promising treatment has been withdrawn — at least for the time being — out of concern over side-effects.
A low-dose version of the anti-obesity drug Xenical (orlistat), marketed as Alli (pronounced AL-EYE), went on sale over-the-counter [...]

Read the full article →

Stay away from these online diet pills, FDA says

Thumbnail image for Stay away from these online diet pills, FDA says

WASHINGTON – If you’re looking for a little help shedding extra pounds after the holidays, the government is warning you to stay away from nearly 30 weight-loss products that contain unlisted and possibly dangerous ingredients.
The pills are advertised as “natural” fat busters and have intriguing names like Imelda Perfect Slim and Zhen de Shou. Some [...]

Read the full article →

3 Drug Companies go to court.

Thumbnail image for 3 Drug Companies go to court.

The Federal Trade Commission (FTC) is taking 3 companies and 2 individuals to court for allegedly inaccurate advertising claims about 2 diet pills.  The pills are Relacore and Akävar 20/50.
Apparently, the complaint states that the defendants made claims to “eat as much as you want and still lose weight”.  These claims were advertised on the [...]

Read the full article →

New Prescription Drugs In The Pipeline

Thumbnail image for New Prescription Drugs In The Pipeline

The New York Times takes a look at some promising drugs in the pipeline and discusses the economic incentive to drug manufacturers developing effective diet pills.  Names we will be hearing in the future are Arena, Orexigen and Vivus.  We will be following the progress of these developmental drugs and reporting on how they advance [...]

Read the full article →

Mirafit FBCx – Making Noise With Clinical Trial Success

Thumbnail image for Mirafit FBCx – Making Noise With Clinical Trial Success

If we told you that there is currently a diet pill developed by two professors at Wayne State University that has demonstrated an exceptional ability to block fat & reduce weight with no significant side effects, you would likely say “I’ve heard that before”.  But the results of the Mirafit FBCx clinical trials were released [...]

Read the full article →